OutSense Diagnostics
Toilet-based IoT Sensor for Detecting GI Conditions
StartupOutSense Diagnostics is a Or Yehuda-based startup in the Health Tech & Life Sciences sector, established in 2016. Toilet-based IoT Sensor for Detecting GI Conditions. The company has raised a total of $4.75M across 5 funding rounds, currently at the Acquired stage. OutSense Diagnostics was founded by Ishay Attar. Key investors include Longevity Venture Partners, Peregrine Ventures, Incentive, among 4 total investors. The company has 11-50 employees. Core technologies: Communications, IOT, Sensing, Platforms & Interfaces, Mobile, Data Storage, Cloud, Artificial Intelligence.
With $4.75M in total funding, OutSense Diagnostics is a Acquired-stage company operating in Health Tech & Life Sciences. The company follows a B2B/B2B2C/B2C business model. Product stage: Clinical Trial. The company holds 1 patent. OutSense Diagnostics has been acquired.
- StageAcquired
- ProductClinical Trial
- ModelB2B, B2B2C, B2C
- Employees11-50
- HQOr Yehuda
- DistrictCenter District
- StatusAcquired
- Last Round$500K
- Longevity Venture PartnersLead
- Peregrine VenturesLead
- Incentive
4 investors total
Ishay AttarFounder & Chairman(no longer with the company)
7 articles covered by sources including thejournalofmhealth.com,
www.calcalistech.com,
www.israel21c.org,
www.thebritishjournal.com,
techweez.com.
What does OutSense Diagnostics do?
OutSense Diagnostics is developing an IoT sensor for wellness monitoring and early detection of illness. The sensor uses imaging technologies to monitor essential health and wellness parameters and communicates them to the user with a mobile app. The company's primary goal is to prevent colorectal cancer by identifying hidden blood in stool. The OutSense clip-on toilet sensor is designed to be user friendly and includes a proprietary optical setup, data acquisition board, connectivity, and a mobile phone app. The hands-free sensor automatically scans every elimination and is capable of identifying minute traces of blood in stool. The OutSense sensor can perform hundreds of measurements per year, improving accuracy and compliance. The OutSense platform is also useful for other GI conditions, such as irritable bowel syndrome, Crohn's disease, and colitis, as well as for lifestyle and personalized nutrition applications.
How much funding has OutSense Diagnostics raised?
OutSense Diagnostics has raised $4.75M in total funding across 5 rounds. The company is currently at the Acquired stage. Key investors include Longevity Venture Partners, Peregrine Ventures, Incentive.
Who founded OutSense Diagnostics?
OutSense Diagnostics was founded in 2016 by Ishay Attar (Founder & Chairman(no longer with the company)).
What sector is OutSense Diagnostics in?
OutSense Diagnostics operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Communications, IOT, Sensing, Platforms & Interfaces, Mobile, Data Storage, Cloud, Artificial Intelligence. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers, Consumers, Demographics & Family, Seniors.
Where is OutSense Diagnostics located?
OutSense Diagnostics is based in Yoni Netanyahu St 6, Or Yehuda, Israel, Center District.